Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1/PHASE2
55 participants
INTERVENTIONAL
2025-03-07
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients?
Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery.
Participants will:
* Receive access to a chatbot for 12 weeks that they can use to prepare for upcoming clinical appointments, find community resources, learn about urge-surfing and wellness techniques, and query for assistance with other recovery-related information and tasks
* Complete surveys and provide user feedback
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults
NCT07214831
Using Smartphones to Provide Recovery Support Services
NCT02132481
Digital Mindfulness-Based Treatment for Substance Use Disorder Recovery
NCT05852015
Data-driven Identification for Substance Misuse
NCT03833804
Substance Use Treatment and Recovery Team (START)
NCT04314648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chatbot
Participants will receive access to a chatbot for 12 weeks that can be used from a mobile device to support follow-up care and recovery needs.
chatbot
Participants will:
* Participate in a baseline session to complete an initial survey and get trained on using the chatbot
* Use the chatbot for 12 weeks and submit a brief weekly survey to provide feedback
* Complete a final survey to provide substance use and health information as well as give feedback on the experience using the chatbot
* Allow access to a limited set of demographic, substance use and health information in electronic health record for study analyses and context.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
chatbot
Participants will:
* Participate in a baseline session to complete an initial survey and get trained on using the chatbot
* Use the chatbot for 12 weeks and submit a brief weekly survey to provide feedback
* Complete a final survey to provide substance use and health information as well as give feedback on the experience using the chatbot
* Allow access to a limited set of demographic, substance use and health information in electronic health record for study analyses and context.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Comfortable with reading, understanding, and communicating in English
* Receiving medication treatment for OUD at MGH?
* Able to participate in a remote interview?
* Own or have reliable access to Wi-Fi or a cellular network
* Willing to use a mobile device to access the chatbot?
Exclusion Criteria
* Unstable medical condition that compromises the ability to safely participate
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of California, Los Angeles
OTHER
Massachusetts General Hospital
OTHER
Dimagi Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Y. Xian Ho, PhD
Role: PRINCIPAL_INVESTIGATOR
Dimagi Inc.
Jonathan Jackson, MEng
Role: PRINCIPAL_INVESTIGATOR
Dimagi Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.